NOT FOR DISTRIBUTION
Header cover image

Bamboos Health Care Holdings

Market Cap

HK$308.0m

Last Updated

2021/04/10 10:38 UTC

Data Sources

Company Financials

Executive Summary

Bamboos Health Care Holdings Limited, an investment holding company, provides healthcare staffing solution services in Hong Kong. More Details


Snowflake Analysis

Flawless balance sheet and good value.

Share Price & News

How has Bamboos Health Care Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 2293 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 2293's weekly volatility (7%) has been stable over the past year.


Market Performance


7 Day Return

-3.8%

2293

-0.04%

HK Healthcare

-0.5%

HK Market


1 Year Return

-33.6%

2293

21.4%

HK Healthcare

29.2%

HK Market

Return vs Industry: 2293 underperformed the Hong Kong Healthcare industry which returned 21.4% over the past year.

Return vs Market: 2293 underperformed the Hong Kong Market which returned 29.2% over the past year.


Shareholder returns

2293IndustryMarket
7 Day-3.8%-0.04%-0.5%
30 Day-6.1%13.9%2.3%
90 Day-9.4%5.4%4.0%
1 Year-29.5%-33.6%24.6%21.4%34.2%29.2%
3 Year-42.3%-50.0%-41.6%-45.4%4.2%-6.8%
5 Year-5.8%-22.2%-41.1%-46.6%48.8%23.7%

Long-Term Price Volatility Vs. Market

How volatile is Bamboos Health Care Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Bamboos Health Care Holdings undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 2293 (HK$0.77) is trading below our estimate of fair value (HK$2.86)

Significantly Below Fair Value: 2293 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 2293 is good value based on its PE Ratio (9.2x) compared to the HK Healthcare industry average (20.5x).

PE vs Market: 2293 is good value based on its PE Ratio (9.2x) compared to the Hong Kong market (11.7x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 2293's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 2293 is overvalued based on its PB Ratio (1.9x) compared to the HK Healthcare industry average (1.3x).


Future Growth

How is Bamboos Health Care Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

21.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bamboos Health Care Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Bamboos Health Care Holdings performed over the past 5 years?

5.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 2293 has high quality earnings.

Growing Profit Margin: 2293's current net profit margins (43.9%) are lower than last year (48.5%).


Past Earnings Growth Analysis

Earnings Trend: 2293's earnings have grown by 5.3% per year over the past 5 years.

Accelerating Growth: 2293's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 2293 had negative earnings growth (-17.1%) over the past year, making it difficult to compare to the Healthcare industry average (1%).


Return on Equity

High ROE: 2293's Return on Equity (20.6%) is considered high.


Financial Health

How is Bamboos Health Care Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 2293's short term assets (HK$85.3M) exceed its short term liabilities (HK$30.9M).

Long Term Liabilities: 2293's short term assets (HK$85.3M) exceed its long term liabilities (HK$1.6M).


Debt to Equity History and Analysis

Debt Level: 2293 is debt free.

Reducing Debt: 2293 had no debt 5 years ago.

Debt Coverage: 2293 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 2293 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Bamboos Health Care Holdings's current dividend yield, its reliability and sustainability?

6.49%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 2293's dividend (6.49%) is higher than the bottom 25% of dividend payers in the Hong Kong market (1.96%).

High Dividend: 2293's dividend (6.49%) is in the top 25% of dividend payers in the Hong Kong market (5.97%)


Stability and Growth of Payments

Stable Dividend: 2293 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 2293's dividend payments have increased, but the company has only paid a dividend for 6 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (59.7%), 2293's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average board tenure


CEO

Winsome Hai (49 yo)

no data

Tenure

HK$3,115,000

Compensation

Ms. Hiu Chu Hai, also known as Winsome, serves as the Chief Executive Officer of Bamboos Health Care Holdings Limited and serves as its Executive Director from March 28, 2014. She serves as the Chairman of...


CEO Compensation Analysis

Compensation vs Market: Winsome's total compensation ($USD400.46K) is above average for companies of similar size in the Hong Kong market ($USD230.00K).

Compensation vs Earnings: Winsome's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Board Members

Experienced Board: 2293's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Bamboos Health Care Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Bamboos Health Care Holdings Limited
  • Ticker: 2293
  • Exchange: SEHK
  • Founded: 2009
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: HK$308.000m
  • Shares outstanding: 400.00m
  • Website: https://www.bamboos.com.hk

Number of Employees


Location

  • Bamboos Health Care Holdings Limited
  • Wing On Plaza
  • 2nd Floor
  • Tsim Sha Tsui
  • Kowloon
  • Hong Kong

Listings


Biography

Bamboos Health Care Holdings Limited, an investment holding company, provides healthcare staffing solution services in Hong Kong. It offers 24-hour private nursing services; home care and consultation solu...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/10 10:38
End of Day Share Price2021/04/09 00:00
Earnings2020/12/31
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.